What is PEPID?
PEPID is a distinguished provider of clinical decision support tools and comprehensive medical reference resources, catering to healthcare professionals, hospitals, and educational institutions. Established in 1994, PEPID has cultivated a robust platform designed to enhance critical decision-making processes by offering readily accessible and integrated drug information and medical content. Its solutions are relied upon by a diverse clientele, including emergency physicians, primary care practitioners, nurse practitioners, and medical students, all of whom benefit from the company's commitment to peer-reviewed content and continuous improvement. PEPID's core mission is to elevate patient outcomes by equipping healthcare providers with essential, up-to-date knowledge precisely when and where it is needed.
How much funding has PEPID raised?
PEPID has raised a total of $656K across 2 funding rounds:
Debt
$350K
Debt
$306K
Debt (2020): $350K with participation from PPP
Debt (2021): $306K led by PPP
Key Investors in PEPID
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for PEPID?
With the recent influx of major enterprise-level funding and a significant strategic investment, PEPID is well-positioned for continued expansion and innovation. The company's focus on providing critical clinical decision support tools suggests that future capital deployment will likely target enhancements to its platform, expansion into new healthcare markets, and the integration of advanced data analytics. This strategic financing indicates a mature stage of development, enabling PEPID to solidify its market leadership and further its mission of improving healthcare delivery through accessible, reliable medical information.
See full PEPID company page
